Brazilian town to receive Pfizer for study

·1-min read

Pfizer Inc plans to study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company has said.

The study will be conducted in Toledo - a town with a population 143,000, in the west of Parana state - as a joint endeavour with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.

Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.

"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with a pharmaceutical company," Pfizer announced in a statement on Wednesday.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting